Cameco (NYSE:CCJ) Sets New 52-Week High – Time to Buy?
by Kim Johansen · The Markets DailyCameco Corporation (NYSE:CCJ – Get Free Report) (TSE:CCO) hit a new 52-week high on Wednesday . The stock traded as high as $129.79 and last traded at $127.9430, with a volume of 1602626 shares trading hands. The stock had previously closed at $125.97.
Analyst Ratings Changes
A number of research firms have recently weighed in on CCJ. National Bankshares restated an “outperform” rating on shares of Cameco in a report on Thursday, November 6th. Wall Street Zen downgraded shares of Cameco from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Glj Research reissued a “buy” rating and set a $99.74 price target on shares of Cameco in a research report on Wednesday, December 3rd. Royal Bank Of Canada reduced their price objective on shares of Cameco from $160.00 to $150.00 and set an “outperform” rating for the company in a research report on Thursday, November 13th. Finally, Sanford C. Bernstein boosted their price objective on Cameco from $100.00 to $101.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 7th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Cameco currently has an average rating of “Buy” and a consensus price target of $121.68.
Get Our Latest Stock Analysis on CCJ
Cameco Price Performance
The stock has a market capitalization of $53.71 billion, a PE ratio of 143.43 and a beta of 1.01. The business’s 50-day moving average price is $99.89 and its 200 day moving average price is $88.82. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.85 and a current ratio of 2.99.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last announced its earnings results on Wednesday, November 5th. The basic materials company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.17). Cameco had a return on equity of 8.58% and a net margin of 15.24%.The business had revenue of $313.74 million during the quarter, compared to the consensus estimate of $531.72 million. During the same quarter in the prior year, the company earned ($0.01) earnings per share. Cameco’s revenue was down 14.7% compared to the same quarter last year. Research analysts forecast that Cameco Corporation will post 1.27 earnings per share for the current year.
Cameco Increases Dividend
The business also recently disclosed an annual dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 1st were given a dividend of $0.24 per share. This is an increase from Cameco’s previous annual dividend of $0.12. The ex-dividend date was Monday, December 1st. This represents a dividend yield of 27.0%. Cameco’s dividend payout ratio is 19.77%.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Financial Consulate Inc. bought a new position in shares of Cameco during the 3rd quarter valued at about $25,000. Nisa Investment Advisors LLC bought a new position in Cameco during the fourth quarter valued at approximately $25,000. Founders Capital Management purchased a new position in shares of Cameco during the fourth quarter worth approximately $27,000. Strategic Advocates LLC bought a new stake in shares of Cameco in the 3rd quarter worth approximately $28,000. Finally, Trust Co. of Vermont boosted its stake in shares of Cameco by 1,029.4% in the 2nd quarter. Trust Co. of Vermont now owns 384 shares of the basic materials company’s stock valued at $29,000 after purchasing an additional 350 shares in the last quarter. Institutional investors own 70.21% of the company’s stock.
About Cameco
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.